Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -554,128 | -715,075 | -361,918 | -50,688 | -267,265 |
| Depreciation Amortization | 26,911 | 24,500 | 4,573 | 7,204 | 5,691 |
| Accounts receivable | -10,461 | -41,835 | -19,576 | -24,240 | -1,251 |
| Other Working Capital | 554,056 | -66,881 | -107,892 | -97,461 | -15,767 |
| Other Operating Activity | 91,088 | 342,828 | 96,153 | -66,811 | 32,772 |
| Operating Cash Flow | $107,466 | $-456,463 | $-388,660 | $-231,996 | $-245,820 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -144,088 | 521,994 | -305,790 | -293,295 | -83,327 |
| PPE Investments | -82,202 | -59,631 | -61,157 | -12,000 | -5,341 |
| Net Acquisitions | N/A | -172,556 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 10,695 | 0 |
| Purchase Sale Intangibles | 108,069 | N/A | 0 | 115,785 | -1,525 |
| Other Investing Activity | 104,569 | -3,082 | -3,541 | 115,785 | -1,525 |
| Investing Cash Flow | $-121,721 | $286,725 | $-370,488 | $-178,815 | $-90,193 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 291,150 | 245,625 | 235,872 | 69,708 | 0 |
| Debt Repayment | N/A | N/A | -267,219 | -54,754 | -7,603 |
| Common Stock Issued | 396,010 | 401,955 | 563,631 | 369,183 | 385,732 |
| Other Financing Activity | -4,837 | -5,026 | -2,134 | 503,945 | 0 |
| Financing Cash Flow | $682,323 | $642,554 | $530,150 | $888,082 | $378,129 |
| Beginning Cash Position | 843,645 | 370,829 | 599,827 | 122,556 | 80,440 |
| End Cash Position | 1,511,713 | 843,645 | 370,829 | 599,827 | 122,556 |
| Net Cash Flow | $668,068 | $472,816 | $-228,998 | $477,271 | $42,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | 107,466 | -456,463 | -388,660 | -231,996 | -245,820 |
| Capital Expenditure | -82,202 | -59,631 | -61,157 | -12,000 | -5,341 |
| Free Cash Flow | 25,264 | -516,094 | -449,817 | -243,996 | -251,161 |